Emergent Biosolutions EBS Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Emergent Biosolutions’s reported figures.
Based on trailing twelve months.
The official record: Emergent Biosolutions’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's return on invested capital?
- Emergent Biosolutions (EBS) reported return on invested capital of 8.4% in Q3 2025.
- How has Emergent Biosolutions's return on invested capital changed year-over-year?
- Emergent Biosolutions's return on invested capital increased by 173.6% year-over-year, from -11.4% to 8.4%.
- What is the long-term trend for Emergent Biosolutions's return on invested capital?
- Over 4 years (2020 to 2024), Emergent Biosolutions's return on invested capital has grown at a -16.8% compound annual growth rate (CAGR), from 18.4% to -8.8%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.